Reduced proteinuria after cessation of long-acting, osmotic release nifedipine GITS in diabetic nephropathy.
Hess
B
B
D000368:Aged; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003692:Delayed-Action Preparations / Q000009:adverse effects*; D003928:Diabetic Nephropathies / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use; D011507:Proteinuria / Q000139:chemically induced*
D002121:Calcium Channel Blockers; D003692:Delayed-Action Preparations; D009543:Nifedipine